↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID21948594.edit
↑Gunja N, Collins M, Graudins A (2004). „A comparison of the pharmacokinetics of oral and sublingual cyproheptadine”. Journal of Toxicology. Clinical Toxicology42 (1): 79–83. PMID15083941.
↑13,013,113,213,313,4Toll L, Berzetei-Gurske IP, Polgar WE,et al. (March 1998). „Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications”. NIDA Research Monograph178: 440–66. PMID9686407.
↑Riccioppo Neto F (March 1979). „The local anesthetic effect of cyproheptadine on mammalian nerve fibres”. European Journal of Pharmacology54 (3): 203–7. DOI:10.1016/0014-2999(79)90078-5. PMID428422.